Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance.
about
targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysisConstruction and analysis of protein-protein interaction networksStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewSequence-based analysis uncovers an abundance of non-coding RNA in the total transcriptome of Mycobacterium tuberculosisIdentification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approachComparative analysis and assessment of M. tuberculosis H37Rv protein-protein interaction datasetsUncovering new signaling proteins and potential drug targets through the interactome analysis of Mycobacterium tuberculosis.Generation and Analysis of Large-Scale Data-Driven Mycobacterium tuberculosis Functional Networks for Drug Target IdentificationIdentifying co-targets to fight drug resistance based on a random walk model.Tuberculosis: global approaches to a global disease.Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance.Cisplatin inhibits protein splicing, suggesting inteins as therapeutic targets in mycobacteria.High-throughput virtual screening of phloroglucinol derivatives against HIV-reverse transcriptase.Structure-based systems biology for analyzing off-target bindingNetwork analyses in systems pharmacology.Systems biology-based identification of Mycobacterium tuberculosis persistence genes in mouse lungsMycobacterium tuberculosis and Clostridium difficille interactomes: demonstration of rapid development of computational system for bacterial interactome prediction.Resistome analysis of Mycobacterium tuberculosis: Identification of aminoglycoside 2'-Nacetyltransferase (AAC) as co-target for drug desigining.A chemical proteomics approach to profiling the ATP-binding proteome of Mycobacterium tuberculosis.A unified statistical model to support local sequence order independent similarity searching for ligand-binding sites and its application to genome-based drug discoveryCytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MSNetwork approaches to drug discovery.Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era.Computational systems approach for drug target discovery.Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein-protein interaction networkAn altered Mycobacterium tuberculosis metabolome induced by katG mutations resulting in isoniazid resistance.Conserved host-pathogen PPIs. Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, and E. coli targeted by PComparative Genome and Network Centrality Analysis to Identify Drug Targets of Mycobacterium tuberculosis H37Rv.Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery.Rationalization and prediction of drug resistant mutations in targets for clinical anti-tubercular drugs.Building protein-protein interaction networks for Leishmania species through protein structural information.The novel responses of ethambutol against Mycobacterium smegmatis mc²155 Revealed by proteomics analysis.Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: a case study on M. tuberculosis.Computational approaches for drug target identification in pathogenic diseasesA systems perspective of host–pathogen interactions: predicting disease outcome in tuberculosis
P2860
Q21202793-574ABB2F-0C2E-4599-B71C-8A03766DF7C5Q24632014-3A01AB47-F272-4F7C-B2AB-C1B02231FF20Q27008867-D8D98EC1-6508-4715-A4AD-9B0A537B581BQ28477804-E393117D-8E93-4936-85BD-345B820AD0B8Q28488335-E56059F8-FA88-4A29-83AE-0C67F856CD19Q30513704-A2DF8F24-1EE3-496E-BAFA-00D0E1AE4646Q33419727-6EF3A5EF-3102-4004-B469-044B7B118BBAQ34108424-62B59525-F08B-433E-AA41-3200DF4403BCQ34132379-5CD8D6E0-03CD-4038-8164-544D913CBE76Q34143218-B90418FC-6FDB-4AAD-98DE-2068DE33BFB9Q34237349-741205C0-2098-4D67-AF9C-44157C9E8776Q34488965-C2005E56-3F6F-4815-A945-53B42F8C538FQ34556651-79393D6F-B80A-46B3-B689-8BB1D6B022FDQ34761978-A270EB54-0761-4587-9D27-E96998952FE4Q34995155-3A757E7E-D657-4B1B-B5C4-B9E52E149A29Q35097013-7D55A5F8-B96D-4C96-BC7F-F3A2EF0D9715Q35965216-A4FB4AC0-A51A-4E50-BF9A-3EA765CBF592Q36700497-343453BD-02A3-484B-81EF-FA2664C7BD5DQ36910805-1E9C65CF-E404-416C-8537-FCBC939D5FE1Q37206373-FB13FE76-7E7F-4ED7-9695-787A25EAECB7Q37413431-C5CC4FF5-1B26-4DD6-B0CA-DC16D836B01FQ38058888-69AE8BAE-75CF-4D63-BB84-681B9829D3D2Q38063490-4E55C175-F34F-4EC1-82AB-F0C60C9F60BCQ38088344-12490EC4-3D94-4D90-9647-4277D8E105EFQ38523914-8FFC1EBB-626A-45F4-83F9-EDD02FBA1E29Q39682367-21778A95-F2BA-4B1F-B8CE-24D5B8960E9DQ41402803-B3C246B7-3214-49ED-BDAA-B46C05832CD0Q42105004-6D49F718-3BEE-43E4-B084-EA5635D9C1C8Q43633453-E131E909-F76F-4BFD-8FD1-948508420551Q43648589-5EFE36DA-5C91-4487-9DB6-1A98AC1CF702Q50420648-0CD7961F-9ACA-44F3-8CC3-D4E923A8C183Q54430301-20CD1D85-12B3-4AA8-9925-D29E3C463FF3Q55464700-6A2B8304-0B0D-4228-8FE4-412ECACBC5A1Q57038529-86948C1E-225D-4108-81C8-266671AF5A50Q57038569-946C8DF2-07E2-49B6-A72F-F45FC8F4D287
P2860
Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mycobacterium tuberculosis int ...... l pathways to drug resistance.
@ast
Mycobacterium tuberculosis int ...... l pathways to drug resistance.
@en
type
label
Mycobacterium tuberculosis int ...... l pathways to drug resistance.
@ast
Mycobacterium tuberculosis int ...... l pathways to drug resistance.
@en
prefLabel
Mycobacterium tuberculosis int ...... l pathways to drug resistance.
@ast
Mycobacterium tuberculosis int ...... l pathways to drug resistance.
@en
P2860
P356
P1433
P1476
Mycobacterium tuberculosis int ...... l pathways to drug resistance.
@en
P2860
P2888
P356
10.1186/1471-2180-8-234
P577
2008-12-23T00:00:00Z
P5875
P6179
1004264417